Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01546298 · ClinicalTrials.gov registry record

Immune Reactions in Contact Dermatitis Affected Skin

A clinical trial, sponsored by Rockefeller University.

Completed
Registry status
9
Enrollment target

NCT01546298 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01546298 has completed, sponsored by Rockefeller University.

COMPLETED
Registry status
9 participants
Enrollment target

Study Summary

This study hopes to improve the investigators understanding of how the immune system acts in allergic contact dermatitis. In order to reach this goal, normal volunteers, who are suspected of having allergic contact dermatitis, will be patch tested for the fifteen most common allergens. Then, biopsies will be taken of the skin at the sites where the there is a positive reaction to the allergen. Also, small biopsies will be taken from an area that received a patch but no allergen and an area that did not receive a patch to serve as controls. In a second stage of the study, volunteers will receive patches with the allergen to which they demonstrated an allergic response. More biopsies will be taken, over three designated time points. The biopsied skin samples will then be studied in a laboratory.

Interventions

  • OTHER Patch tests

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2012-01
Est. Completion 2012-12-14

Sponsor

Rockefeller University

117 total trials

What the Registry Record Tells You About NCT01546298

The ClinicalTrials.gov registry entry for NCT01546298 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Patch tests is the first listed.

NCT01546298 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01546298 about?

NCT01546298 is a clinical study titled "Immune Reactions in Contact Dermatitis Affected Skin". This study hopes to improve the investigators understanding of how the immune system acts in allergic contact dermatitis. In order to reach this goal, normal volunteers, who are suspected of having allergic contact dermatitis, will be patch tested for the fifteen most common allergens. Then, biopsie...

What is the current status of trial NCT01546298?

This trial is currently completed. The enrollment target is 9 participants. The study started on 2012-01. Estimated completion is 2012-12-14.

What interventions are being tested in trial NCT01546298?

The interventions under investigation include: Patch tests (OTHER).

Who is sponsoring clinical trial NCT01546298?

This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.